Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

Novel prostaglandin D2 agonists from Glaxo Wellcome

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

COX-2 inhibitor reported by Searle

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Atypical antipsychotics from Spanish university

April 12, 1996

New alpha2-adrenoceptor agonist reported by Allergan

April 12, 1996

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

COX-2 inhibitor research continues at Merck Frosst

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...